These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 14699506)
1. Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer. Wang L; Hernández-Alcoceba R; Shankar V; Zabala M; Kochanek S; Sangro B; Kramer MG; Prieto J; Qian C Gastroenterology; 2004 Jan; 126(1):278-89. PubMed ID: 14699506 [TBL] [Abstract][Full Text] [Related]
2. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma]. Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324 [TBL] [Abstract][Full Text] [Related]
3. Therapy of cancer by cytokines mediated by gene therapy approach. Qian C; Liu XY; Prieto J Cell Res; 2006 Feb; 16(2):182-8. PubMed ID: 16474432 [TBL] [Abstract][Full Text] [Related]
4. In vivo ligand-inducible regulation of gene expression in a gutless adenoviral vector system. Zerby D; Sakhuja K; Reddy PS; Zimmerman H; Kayda D; Ganesh S; Pattison S; Brann T; Kadan MJ; Kaleko M; Connelly S Hum Gene Ther; 2003 May; 14(8):749-61. PubMed ID: 12804138 [TBL] [Abstract][Full Text] [Related]
5. Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment. Poutou J; Bunuales M; Gonzalez-Aparicio M; German B; Zugasti I; Hernandez-Alcoceba R J Control Release; 2017 Dec; 268():247-258. PubMed ID: 29074407 [TBL] [Abstract][Full Text] [Related]
6. Regulated and prolonged expression of mIFN(alpha) in immunocompetent mice mediated by a helper-dependent adenovirus vector. Aurisicchio L; Bujard H; Hillen W; Cortese R; Ciliberto G; La Monica N; Palombo F Gene Ther; 2001 Dec; 8(24):1817-25. PubMed ID: 11821934 [TBL] [Abstract][Full Text] [Related]
7. Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver. Sung MW; Chen SH; Thung SN; Zhang DY; Huang TG; Mandeli JP; Woo SL Hum Gene Ther; 2002 Apr; 13(6):731-43. PubMed ID: 11936972 [TBL] [Abstract][Full Text] [Related]
8. Combined therapy with cytokine-induced killer cells and oncolytic adenovirus expressing IL-12 induce enhanced antitumor activity in liver tumor model. Yang Z; Zhang Q; Xu K; Shan J; Shen J; Liu L; Xu Y; Xia F; Bie P; Zhang X; Cui Y; Bian XW; Qian C PLoS One; 2012; 7(9):e44802. PubMed ID: 23028626 [TBL] [Abstract][Full Text] [Related]
9. Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression. Unzu C; Melero I; Hervás-Stubbs S; Sampedro A; Mancheño U; Morales-Kastresana A; Serrano-Mendioroz I; de Salamanca RE; Benito A; Fontanellas A Gene Ther; 2015 Nov; 22(11):856-65. PubMed ID: 26125605 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors. Song W; Kong HL; Traktman P; Crystal RG Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738 [TBL] [Abstract][Full Text] [Related]